Agencia Espacial Mexicana

Plans for a National Rocket and Space Center in the Yucatán Peninsula Are Underway

Retrieved on: 
Tuesday, January 16, 2024

The project takes inspiration from the renowned U.S. Space and Rocket Center in Huntsville, Alabama, and aims to position Mexico as a key player in the expanding space economy.

Key Points: 
  • The project takes inspiration from the renowned U.S. Space and Rocket Center in Huntsville, Alabama, and aims to position Mexico as a key player in the expanding space economy.
  • The National Rocket and Space Center will be a multifaceted facility, featuring cutting-edge amenities such as a museum, observatory, and immersive experiences for the public.
  • It will also house space camps designed to provide hands-on training for students and individuals interested in space operations.
  • For media inquiries related to the National Rocket and Space Center project, interested parties can contact Merida Aerospace Mexico office at +52 999 282 9050 or email [email protected] .

University of Phoenix alum Dr. Fernando De La Peña Llaca’s holoportation technology and expertise recognized by NASA

Retrieved on: 
Wednesday, June 14, 2023

University of Phoenix celebrates the recognition by National Aeronautics and Space Administration (NASA) of alum Dr. Fernando De La Peña Llaca, CEO & President of AEXA Aerospace (AEXA), in bringing holoportation technology to medicine in space.

Key Points: 
  • University of Phoenix celebrates the recognition by National Aeronautics and Space Administration (NASA) of alum Dr. Fernando De La Peña Llaca, CEO & President of AEXA Aerospace (AEXA), in bringing holoportation technology to medicine in space.
  • “Holoportation brings a meaningful connection to medicine and the isolation of situations like space habitation,” shares De La Peña Llaca.
  • De La Peña Llaca established AEXA Aerospace in 2012, at the same time he began his master's degree at University of Phoenix.
  • De La Peña Llaca is a past recipient of the Small Business Administration award, Small Business Champion of the Year, Houston District.

Satellogic Reports Full Year 2022 Financial Results and Provides Business Update

Retrieved on: 
Thursday, April 27, 2023

Satellogic Inc. (NASDAQ: SATL), a leader in sub-meter resolution Earth Observation (“EO”) data collection, today provided full year 2022 financial results and a business update.

Key Points: 
  • Satellogic Inc. (NASDAQ: SATL), a leader in sub-meter resolution Earth Observation (“EO”) data collection, today provided full year 2022 financial results and a business update.
  • “Our new Space Systems (satellite sales) business creates a satellite purchase program that aims to lower the financial barrier to Earth Observation spacecraft ownership.
  • Our revenue grew 42% to $6.0 million for the full year of 2022 and we reduced our net loss from $96.3 million in 2021 to $36.6 million in 2022.
  • We use these Non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons.

Satellogic Signs Letter of Intent with Mexico’s Space Agency for Dedicated Satellite Earth Observation Program

Retrieved on: 
Tuesday, December 13, 2022

Satellogic will host a team of AEM executives and experts at its Pilot Plant in Montevideo, Uruguay, for a facility tour early next year.

Key Points: 
  • Satellogic will host a team of AEM executives and experts at its Pilot Plant in Montevideo, Uruguay, for a facility tour early next year.
  • Satellogic recently signed a three-year program agreement with the Republic of Albania, which includes training of remote-sensing specialists to bolster Albanias domestic workforce.
  • This solution is one of the many ways Satellogic is working to remove barriers and increase access to EO technology and data.
  • Using its patented Earth imaging technology, Satellogic unlocks the power of EO to deliver high-quality, planetary insights at the lowest cost in the industry.

LIXTE BIOTECHNOLOGY ANNOUNCES APPROVAL OF A PHASE 1B/2 RANDOMIZED TRIAL OF DOXORUBICIN +/-LB-100 IN ADVANCED SOFT TISSUE SARCOMAS TO BE CONDUCTED BY THE SPANISH SARCOMA GROUP

Retrieved on: 
Thursday, October 13, 2022

In animal models, LB-100 has consistently enhanced the anti-tumor activity of doxorubicin without apparent increases in toxicity.

Key Points: 
  • In animal models, LB-100 has consistently enhanced the anti-tumor activity of doxorubicin without apparent increases in toxicity.
  • Dr. Kovach continued, This study was designed and will be carried out by the Spanish Sarcoma Group ( Grupo Espaol de Investigacin en Sarcomas, or GEIS ).
  • GEIS was formed in 1994 by oncologists from four hospitals and has grown to include members from more than 60 medical centers across Spain.
  • GEIS will lead a European initiative to conduct a Phase 1/randomized II trial exploring the combination of doxorubicin plus LB-100 in first line of advanced soft tissue sarcomas.

Voyager Space and Nanoracks Sign MOUs with Five Latin American Space Agencies

Retrieved on: 
Sunday, September 18, 2022

PARIS, Sept. 18, 2022 /PRNewswire/ -- Voyager Space, a global leader in space exploration, and its operating company Nanoracks, today announced while at the International Astronautical Congress (IAC) that the company has signed Memorandums of Understanding (MoUs) with the Colombian Space Agency, El Salvador Aerospace Institute, the Mexican Space Agency, the Guatemalan Association of Space Sciences and Engineering, and the Costa Rican startup Orbital Space Technologies. Nanoracks and Voyager signed an individual MoU with each agency, with the intent of opening up access to space and furthering commercial space opportunities within the respective countries.

Key Points: 
  • Nanoracks and Voyager signed an individual MoU with each agency, with the intent of opening up access to space and furthering commercial space opportunities within the respective countries.
  • "Nanoracks has been focused on making space accessible since day one, and we are proud to carry the legacy forward from the International Space Station to Starlab.
  • "Voyager and Nanoracks are making waves with the development of Starlab while simultaneously moving the future of commercial space forward.
  • Nanoracks, powered by Voyager Space , is a global leader for providing commercial space services.

Linneo Health awarded EU Good Manufacturing Practice (GMP) Part I license

Retrieved on: 
Tuesday, September 13, 2022

EU-GMP certification is recognised by all medicine regulatory agencies within the EU, as well as the majority of leading agencies over the world.

Key Points: 
  • EU-GMP certification is recognised by all medicine regulatory agencies within the EU, as well as the majority of leading agencies over the world.
  • Don Bellamy, Chief Executive Officer of Linneo Health, said: Im delighted to share the news of our GMP Part I certification, which marks a further milestone for Linneo.
  • Obtaining EU GMP Part I certification of our dried flower facilities perfectly complements our existing Part II license.
  • Maria Jos Garcia, Quality and RA Director of Linneo Health, added: At Linneo we work continuously to ensure our facilities meet the strictest EU GMP requirements.

Linneo Health expands medicinal cannabis offering to include industrial cannabis derivatives, following the issuing of EU-GMP certification to Alcaliber´s industrial facility

Retrieved on: 
Thursday, July 28, 2022

Linneo Health expands medicinal cannabis offering to include industrial cannabis derivatives, following the issuing of EU-GMP certification to Alcalibers industrial facility

Key Points: 
  • Linneo Health expands medicinal cannabis offering to include industrial cannabis derivatives, following the issuing of EU-GMP certification to Alcalibers industrial facility
    Linneo Health to expand offering of medicinal cannabis products to include APIs and cannabis extracts, under the terms of a CDMO agreement with Alcaliber
    Madrid, Spain, 28 July 2022: Linneo Health, a global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing, and Alcaliber, a leading independent supplier of intermediates and active pharmaceutical ingredients (APIs) to the global pharmaceutical industry, today announce an expanded medicinal cannabis offering by Linneo Health to include industrial derivatives.
  • EU-GMP certification is recognised by all medicine regulatory agencies within the EU, as well as a number of leading agencies over the world.
  • Alcalibers new GMP certification allows for an important expansion in Linneo Healths medicinal product offering, and ensures that Linneos commitment to deliver cannabis products of the highest GMP standards is extended into cannabis extracts.
  • Linneo Health offers its customers unrivalled experience in the research, cultivation and supply of medicinal cannabis, leveraging a deep heritage of leadership and know-how in the production of strictly regulated pharmaceutical products.

Registration Now Open for NASA 2022 International Space Apps Challenge

Retrieved on: 
Friday, July 15, 2022

WASHINGTON, July 15, 2022 /PRNewswire/ -- The NASA International Space Apps Challenge the world's largest annual hackathon returns this year with the theme "Make Space," which emphasizes NASA's commitment to inclusivity.

Key Points: 
  • WASHINGTON, July 15, 2022 /PRNewswire/ -- The NASA International Space Apps Challenge the world's largest annual hackathon returns this year with the theme "Make Space," which emphasizes NASA's commitment to inclusivity.
  • "Each year, Space Apps allows thousands to engage with NASA and its partners' open data during the hackathon," said Thomas Zurbuchen, NASA associate administrator for the agency's Science Mission Directorate.
  • This year NASA is excited to announce the addition of the Indian Space Research Organization and Mexican Space Agency to the roster of space agency partners supporting Space Apps.
  • Valued partners returning from last year include Australian Space Agency, Brazilian Space Agency, Canadian Space Agency, ESA (European Space Agency), Japan Aerospace Exploration Agency, National Space Activities Commission of Argentina, National Space Science Agency of Bahrain, Paraguayan Space Agency, and the South African National Space Agency.

University of Phoenix Alum Dr. De La Peña Llaca’s Holoportation Technology and Expertise Featured in NASA Project

Retrieved on: 
Thursday, May 5, 2022

University of Phoenix celebrates the success of alum Dr. Fernando De La Pea Llaca in bringing holoportation technology to medicine in space.

Key Points: 
  • University of Phoenix celebrates the success of alum Dr. Fernando De La Pea Llaca in bringing holoportation technology to medicine in space.
  • I have 28 years of experience leading technology companies; however, space exploration has always motivated me, shares De La Pea Llaca.
  • De La Pea Llaca established AEXA Aerospace in 2012, at the same time he began his master's degree at University of Phoenix.
  • The NASA surgeon agreed and supported the effort, and the result was the successful October 2021 testing of the holoportation technology.